# US 10,478,132 B2 · Glucose conjugated gold nanoparticle

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 10,478,132 B2
- Document ID: US10478132B2
- Status: Granted
- Kind: B2
- Application number: 15/396,881
- Filed: 2017-01-03
- Published: 2017-07-06
- Granted: 2019-11-19
- Earliest claimed: 2016-01-03
- Assignees: Bar-Ilan University
- Applicants: Bar-Ilan University
- Inventors: Rachela Popovtzer; Menachem Motiei; Tamar Dreifuss
- Web page: https://patentgrep.com/patent/US10478132B2

## CPC

- A61B 5/7282: {Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818)}
- A61B 5/0036: {including treatment, e.g., using an implantable medical device, ablating, ventilating}
- A61K 49/06: Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- G01N 21/3103: {Atomic absorption analysis}
- A61B 5/064: {using markers (A61B5/062 takes precedence)}
- A61B 5/6867: {specially adapted to be attached or implanted in a specific body part (A61B5/6847 takes precedence)}
- A61B 8/481: {involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream}
- A61B 2505/05: Surgical care
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Composition methods and kits for diagnosing and treating tumors within a subject. The compositions disclosed comprise: a gold nanoparticle; PEG or derivatives thereof, wherein said PEG or derivatives thereof have a molecular weight of 400 to 1500 Dalton; and a 2-Deoxy-D-glucose, wherein the PEG or derivatives thereof are linked to the gold nanoparticle and to said 2-Deoxy-D-Glucose, and wherein the 2-Deoxy-D-Glucose is linked to the PEG or derivatives thereof at the 2-Carbon position of the 2-Deoxy-D-Glucose.

## Claims

### Claim 1

A composition comprising:
a gold nanoparticle;
PEG or derivatives thereof, wherein said PEG and derivatives thereof have a molecular weight of 400 to 1000 Dalton; and
a 2-Deoxy-D-glucose,
wherein said PEG or derivatives thereof are linked to said gold nanoparticle and to said 2-Deoxy-D-Glucose, wherein said PEG or derivatives thereof are linked to said gold nanoparticle via a chemical attachment selected from the group consisting of: covalent attachment, semi-covalent attachment and non-covalent attachment,
wherein said 2-Deoxy-D-Glucose is linked to said PEG and derivatives thereof at the 2-Carbon position of said 2-Deoxy-D-Glucose; and
wherein said composition has a diameter of 20 to 60 nanometers.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said gold has a concentration of 30 to 60 milligrams/milliliter.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said 2-Deoxy-D-Glucose is covalently linked to said PEG.

### Claim 4 (depends on 1)

The composition of claim 1, wherein said PEG or derivatives thereof comprise one or more functional groups selected from the group consisting of: mercapto group, carboxyl group, mercaptoethyl, carboxyethyl, hydroxyl, amine, imide, sulfone, disulfide, and NHS esters.

### Claim 5 (depends on 1)

The composition of claim 1, wherein said gold nanoparticle is linked to 4,000-20,000 molecules of said PEG or derivative thereof.

### Claim 6 (depends on 1)

The composition of claim 1, wherein said gold nanoparticle is linked to 4,000-20,000 molecules of said 2-deoxy-D-glucose.

### Claim 7 (depends on 1)

The composition of claim 1, wherein said gold nanoparticle has a diameter of 10 to 40 nanometers.

### Claim 8 (depends on 1)

The composition of claim 1, further comprising a drug.

### Claim 9 (depends on 8)

The composition of claim 8, wherein said drug is an anti-cancer therapeutic agent.

### Claim 10 (depends on 1)

A method of imaging a tumor comprising:
administering to a subject the composition of claim 1, allowing said composition to penetrate and accumulate in tumor cells; and
scanning said subject or a portion thereof using a diagnostic imaging technique, thereby imaging said tumor cells.

### Claim 11 (depends on 10)

The method of claim 10, wherein said diagnostic imaging technique is selected from the group consisting: computed X-ray tomography (CT), ultrasound (US) and magnetic resonance imaging (MM).

### Claim 12 (depends on 10)

The method of claim 10, wherein said administering is by an intravenous injection.

### Claim 13 (depends on 10)

The method of claim 10, wherein said scanning is performed 0.5 to 24 hours post said administering.

### Claim 14 (depends on 10)

The method of claim 10, wherein said subject is a human subject.

### Claim 15 (depends on 10)

The method of claim 10, wherein said subject is at risk of being afflicted with cancer.

### Claim 16 (depends on 10)

The method of claim 10, wherein said drug is an anti-cancer therapeutic agent.

### Claim 17 (depends on 16)

The method of claim 16, wherein said drug is activated within said tumor cells.

### Claim 18 (depends on 10)

The method of claim 10, further comprising a step of directing an ionizing irradiation to the composition thereby obtaining locally enhanced radiation therapy within said tumor cells.
